Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronicn         heart failure patients

Carlo A. Gaillard

首页> 外文期刊>European Journal of Heart Failure >Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronicn heart failure patients

【24h】

Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronicn heart failure patients

机译：Hepcidin-25是慢性肾脏疾病/慢性心力衰竭患者对外源促红细胞生成素的反应而非抵抗的标志物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Heart Failure》 |2010年第9期|p.943-950|共8页
作者
Carlo A. Gaillard;
展开▼
作者单位

Meander MC Amersfoort, @%@, UMC Utrecht, @%@, UMC Utrecht, @%@, Lange Land Hospital, @%@, Meander MC Amersfoort, @%@, Radboud University Nijmegen Medical Centre, @%@, University of Alberta, @%@, VU University Medical Center, @%@Corresponding author. Tel;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients. [J] . van der Putten K, Jie KE, van den Broek D, European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2010,第9期

机译：Hepcidin-25是慢性肾脏疾病/慢性心力衰竭患者对外源促红细胞生成素的反应而非抵抗的标志物。
2. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronicn kidney disease [J] . Sendogan Aker European Journal of Heart Failure . 2012,第5期

机译：腹膜透析可缓解临床症状，并且对于顽固性心力衰竭和慢性肾脏病患者具有良好的耐受性
3. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. [J] . van-der-Putten K, Braam B, Jie KE, Nature clinical practice. Nephrology . 2008,第1期

机译：疾病机理：心肾衰竭患者的促红细胞生成素抵抗。
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. The Effects of Fish Oil Supplementation on Inflammation Markers in Chronic Kidney Disease Patients. [D] . Deike, Erika. 2010

机译：补充鱼油对慢性肾脏病患者炎症标志物的影响。
6. Inflammation markers and Major Depressive Disorder in Patients with Chronic Heart Failure: Results from the Sertraline Against Depression and Heart Disease in Chronic Heart Failure (SADHART-CHF) study [O] . Glen L. Xiong, Kevin Prybol, Stephen H. Boyle, -1

机译：慢性心力衰竭患者的炎症标志物和严重抑郁障碍：舍曲林抗抑郁和心脏病的结果在慢性心力衰竭（SADHART-CHF）研究中
7. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients† [O] . Karien van der Putten, Kim E. Jie, Daan van den Broek, 2010

机译：Hepcidin-25是响应的标志物而不是慢性肾病/慢性心力衰竭患者的外源性促红细胞生成素的标志物

Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronicn heart failure patients

著录项

相似文献

相关主题

期刊订阅